Mabqi specializes in the discovery and development of human therapeutic antibodies. Our core technology is based on proprietary synthetic fully human libraries including pH-sensitive variants tailored for oncology applications.
The company offers end-to-end discovery solutions, from antibody discovery, affinity maturation to optimization and full characterization, ensuring tailored support and delivery of high-quality and developable antibodies to meet your needs.
Moreover, based on our know-how and technologies, Mabqi is committed to the discovery of therapeutic antibodies on innovative targets with off-the-shelf antibody assets available for partnered development and licensing opportunities.
Company Details
- Employees
- 26
- Founded
- 2017
- Address
- 1682, Rue De La Valsière, Grabels,occitanie 34790,france
- Industry
- Biotechnology
- Website
- imab-labs.com
- Keywords
- Antibody Discovery, Fully Human Antibody Discovery, Antibody optimization, Antibody affinity maturation, Phage display, Yeast display, Naive Libraries, Antibody Development, pH sensitive antibodies, Therapeutic antibodies, Monoclonal antibodies, Multispecific Antibodies, Various Antibody Formats, ADC, Conditional activation, drug conjugate, in vitro display, Human Antibodies, TCE, Bispecific, Synthetic antibody library, GPCR, ion channel, Peptide, protein, Oncology, Immuno-oncology, Inflammation, Infectious.
- HQ
- Grabels, Occitanie
Mabqi Questions
Mabqi's website is imab-labs.com
Mabqi's LinkedIn profile is https://fr.linkedin.com/company/mabqi-labs
Mabqi has
26 employees.
View email and phone details for 26
employees at Mabqi.
Mabqi's industry is
Biotechnology
Mabqi's top competitors are
Cilcare,
Mb Therapeutics,
Sensorion,
Greenphage,
Ciloa Sas,
Phost'in Therapeutics,
Medincell,
Acobiom,
Terratis,
Azelead.
Mabqi's categories are Biotechnology
Mabqi's founding year is 2017
